MA11.07 Phase 1/2 TRIDENT-1 Study of Repotrectinib in Patients with ROS1+ or NTRK+ Advanced Solid Tumors

B.C. Cho, Robert C. Doebele, W. Marston Linehan, Misako Nagasaka, Christina S. Baik, Anthonie J. van der Wekken, V. Velcheti, K.H. Lee, S. Liu, Benjamin Solomon, Steven Kao, Matthew Krebs, Viola W. Zhu, Shanna Stopatschinskaja, D. Ross Camidge, Alexander Drilon